Denver-based Soar Autism Center, a leading Autism Therapy Center Denver families trust, has raised approximately $16 million in Series A equity funding, positioning itself for rapid growth in the behavioral health space. The funding will allow the company to expand its clinical footprint, enhance business systems, and grow its employee headcount, ensuring families have access to high-quality care.
Founders and Company Background
Founded in 2020 by husband-and-wife duo Ian and Jennifer Goldstein, Soar Autism Center has quickly become a trusted Autism Therapy Center Denver families rely on. Ian Goldstein serves as CEO, while Jennifer Goldstein serves as COO. The company operates four centers across the Denver metro area, offering naturalistic Applied Behavior Analysis (ABA) therapy, speech therapy, occupational therapy, psychological services, and diagnostic evaluations. Soar’s care centers on the Early Start Denver Model, a leading evidence-based framework for young children with autism.
Series A Funding Details
In a public filing, Soar Autism Center disclosed raising $15.9 million in this Series A round, with CEO Ian Goldstein noting that the total could reach $16.9 million when the round officially closes. The first offering in the Series A round sold on November 23, 2022, and included 19 investors. Since January 2021, the company has raised a total of $19.5 million under its corporate entity, Soar Health Inc.
“This [round] comes with the backdrop of our unique clinical model,” Goldstein told Behavioral Health Business. “To do that well and with fidelity requires a broader group of clinical experts to bring that alive at scale.” This commitment to high-quality care makes Soar a standout Autism Therapy Center Denver families can trust.
Expansion Plans
Looking ahead, Soar Autism Center plans to expand further across Colorado, with potential growth opportunities outside the state under consideration. Goldstein emphasized that it is too early to share specifics on out-of-state expansion, but the Series A funding ensures the company has the resources needed to scale while maintaining clinical excellence.
Growing Demand for Autism Services
The demand for autism-related therapies has grown substantially in recent years. Legislative efforts requiring insurance coverage for certain services, combined with increasing awareness and detection of autism, have created strong market opportunities for providers. Autism now affects roughly 1 in 32 to 1 in 29 children nationally, with Colorado’s 2020 CDC estimate at 1 in 76. With rising prevalence, the need for reliable and comprehensive care providers has never been greater.
Comprehensive Care Model
Soar Autism Center has positioned itself as a leading Autism Therapy Center Denver families can turn to for comprehensive care. Its combination of ABA therapy, speech and occupational therapy, diagnostic services, and psychological support ensures children receive individualized treatment tailored to their needs.
Operational Growth
The Series A funding will also support Soar Autism Center’s operational growth, including enhancements to staff training, clinical protocols, and business systems. Expanding the team of highly trained professionals is essential for delivering its model of care consistently across multiple centers. By investing in both clinical and operational infrastructure, Soar is positioning itself as a scalable, high-quality Autism Therapy Center Denver capable of meeting growing demand.
Investor Interest and Market Trends
Investors are increasingly drawn to autism care providers, recognizing both the rising demand and the potential to build platform businesses. Soar Autism Center exemplifies this trend, combining evidence-based therapy, operational efficiency, and strong clinical leadership. The funding marks a significant step toward the company’s long-term growth strategy.
Looking Ahead
With this new capital, Soar Autism Center aims to solidify its role as a premier Autism Therapy Center Denver, serving more families and expanding access to comprehensive, high-quality care. As the company grows, it is well-positioned to continue delivering on its mission of helping children with autism reach their full potential while maintaining the clinical excellence that sets it apart.
